Novo Holdings portfolio company Bolt Biotherapeutics announces closing of IPO

Novo Holdings portfolio company Bolt Biotherapeutics announces closing of IPO

Date
February 9, 2021

Novo Holdings would like to congratulate our portfolio company Bolt Biotherapeutics Inc (NASDAQ: BOLT) on their recent IPO.  Bolt Biotherapeutics is a clinical-stage immuno-oncology company developing tumor-targeted therapies that leverage the power of the innate and adaptive immune systems.

For further information, please find the full statement here.